# Pilot Study of OXP001 and Brufen in Healthy Subjects

> **NCT02050958** · PHASE1 · COMPLETED · sponsor: **Oxford Pharmascience Ltd** · enrollment: 43 (actual)

## Conditions studied

- NSAID Related Gastric Irritation

## Interventions

- **DRUG:** OXP001
- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT02050958
- **Lead sponsor:** Oxford Pharmascience Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-03
- **Final completion:** 2014-04
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2014-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02050958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02050958, "Pilot Study of OXP001 and Brufen in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02050958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*